A detailed history of Kooman & Associates transactions in Johnson & Johnson stock. As of the latest transaction made, Kooman & Associates holds 1,549 shares of JNJ stock, worth $225,503. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,549
Holding current value
$225,503
% of portfolio
0.09%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$145.48 - $167.38 $225,348 - $259,271
1,549 New
1,549 $251 Million
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $208,393 - $233,454
-1,338 Closed
0 $0
Q2 2023

Nov 03, 2023

BUY
$154.35 - $166.11 $5,865 - $6,312
38 Added 2.92%
1,338 $221,000
Q2 2023

Jul 20, 2023

BUY
$154.35 - $166.11 $5,865 - $6,312
38 Added 2.92%
1,338 $221 Million
Q1 2023

Nov 03, 2023

SELL
$151.05 - $180.26 $5,286 - $6,309
-35 Reduced 2.62%
1,300 $202 Million
Q1 2023

Apr 21, 2023

SELL
$151.05 - $180.26 $5,286 - $6,309
-35 Reduced 2.62%
1,300 $202 Million
Q4 2022

Nov 03, 2023

SELL
$160.2 - $179.79 $480 - $539
-3 Reduced 0.22%
1,335 $236 Million
Q4 2022

Jan 24, 2023

BUY
$160.2 - $179.79 $213,866 - $240,019
1,335 New
1,335 $236 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Kooman & Associates Portfolio

Follow Kooman & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kooman & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Kooman & Associates with notifications on news.